Prism BioLab

Grove Biopharma

Grove Biopharma develops synthetic protein mimetics for pharmaceutical and biotechnology companies to target intracellular protein-protein interactions for treating cancer and other diseases.

Sibylla Biotech

This company develops small molecule protein degraders for pharmaceutical partners and clinical research to treat oncological and neurodegenerative diseases.

Pepper Bio

This company develops transomics software to identify biological targets and drug candidates for pharmaceutical and biotechnology researchers.

Technology-enabled pharmaceutical company

This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.

CrystalsFirst GmbH

This company provides structural biology and AI-driven drug discovery services to pharmaceutical and biotechnology organisations for small-molecule development.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Ladder Bio

This biotechnology company develops ladder-shaped therapeutic molecules to provide pharmaceutical partners with oral medicines for targets that are currently difficult to drug.

Think Bioscience

This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.